Feedback / Questions
ondansetron ultra-low dose (AD04) - Adial
https://www.globenewswire.com/news-release/2025/02/19/3028804/26135/en/Adial-Pharmaceuticals-Granted-New-U-S-Patent-Expanding-Coverage-of-its-Genetic-Based-Approach-to-Treating-and-Diagnosing-Alcohol-Use-Disorder-and-Other-Drug-Dependencies.html
Feb 19, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next